<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.9.1" -->
<rss version="0.92">
<channel>
	<title>Drug Lawsuits &#124; Drug Attorneys &#38; Lawyers</title>
	<link>http://www.drug-attorneys.com</link>
	<description></description>
	<lastBuildDate>Thu, 11 Mar 2010 22:23:20 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Fosamax Femur Fracture Lawsuits</title>
		<description><![CDATA[Fosamax (alendronate sodium) is an osteoporosis drug manufactured by Merck to treat bone loss. Fosamax is prescribed to millions of people to reduce the risk of bone fractures, primarily involving the hip. Hundreds of Fosamax lawsuits have already been filed by consumers who experienced severe side effects from taking Fosamax. These side effects included a [...]]]></description>
		<link>http://www.drug-attorneys.com/drugs/fosamax-femur-fracture-lawsuits-03092010</link>
			</item>
	<item>
		<title>Cold Therapy Lawsuits</title>
		<description><![CDATA[Cold Therapy Machines Under Investigation
Chronic pain and permanent nerve damage resulting from exposure to cold therapy, ice machines, recirculating ice coolers, cryotherapy and other forms of cold treatment are why numerous consumers are filing cold therapy lawsuits. Several manufacturers of cold therapy machines are being investigated for defective equipment and design flaws that may have [...]]]></description>
		<link>http://www.drug-attorneys.com/medical-devices/cold-therapy-lawsuits-03042010</link>
			</item>
	<item>
		<title>Cold Therapy Nerve Damage Lawsuits</title>
		<description><![CDATA[Prolonged exposure to cold therapy, ice machines, recirculating ice coolers, cryotherapy and other forms of cold treatment may cause skin damage, permanent nerve damage, and chronic pain to patients. A case report entitled, Cryotherapy Can Cause Permanent Nerve Damage, was published in the American Journal of Pain Management in April of 2004. The case study [...]]]></description>
		<link>http://www.drug-attorneys.com/medical-devices/cold-therapy-nerve-damage-lawsuits-02242010</link>
			</item>
	<item>
		<title>Depakote Spina Bifida Lawsuits</title>
		<description><![CDATA[Depakote is used to treat long-term manic and depressive parts of rapidly-cycling bipolar disorder, migraines, epilepsy and chronic pain associated with nervous system diseases. Marketed by Abbott Laboratories, Depakote is a widely used drug. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be [...]]]></description>
		<link>http://www.drug-attorneys.com/drugs/depakote-spina-bifida-lawsuits-02012010</link>
			</item>
	<item>
		<title>Byetta Pancreatitis Lawsuits</title>
		<description><![CDATA[The FDA has issued numerous warnings regarding Byetta side effects. Serious side effects from the use of Byetta may include acute pancreatitis, hemorrhagic pancreatitis or necrotizing pancreatitis. Pancreatitis is an inflammation of the pancreas that can cause bleeding, tissue damage and infection. The FDA warns that at least two people have died as a result [...]]]></description>
		<link>http://www.drug-attorneys.com/drugs/byetta-pancreatitis-lawsuits-01012010</link>
			</item>
	<item>
		<title>Qualitest Pharmaceuticals Recalls Accusure Insulin Syringes</title>
		<description><![CDATA[Qualitest Pharmaceuticals Issues a Nationwide Recall of All Accusure® Insulin Syringes
Qualitest Pharmaceuticals today issued a voluntary nationwide recall of all Accusure® Insulin Syringes. The distributed syringes are of the following descriptions and NDC numbers: 28G 1/2cc, NDC 0603-6995-21;28G 1cc, NDC 0603-6996-21; 29G 1/2cc NDC 0603-6997-21, 29G 1cc, NDC 0603-6998-21, 30G 1/2cc, NDC 0603-999-21, 30G 1cc, [...]]]></description>
		<link>http://www.drug-attorneys.com/news/qualitest-pharmaceuticals-recalls-accusure-insulin-syringes-10272009</link>
			</item>
	<item>
		<title>American Regent Recalls Ketorolac Tromethamine Injection</title>
		<description><![CDATA[American Regent Voluntarily Recalls All Lots of Ketorolac Tromethamine Injection, USP 30 mg/mL; 1mL and 2mL Single Dose Vials
American Regent conducts nationwide voluntary recall of ALL lots of its Ketorolac Tromethamine Injection, USP 30 mg/mL:

NDC# 0517-0801-25 30 mg/mL 1mL Single Dose Vial
NDC# 0517-0902-25 30mg/mL 2mL Single Dose Vial (60mg/2mL)

This voluntary recall is due to the [...]]]></description>
		<link>http://www.drug-attorneys.com/fda-reports/fda-recalls/american-regent-recalls-ketorolac-tromethamine-injection-10202009</link>
			</item>
	<item>
		<title>Unomedical Recalls Manual Pulmonary Resuscitators (MPRs)</title>
		<description><![CDATA[Unomedical Inc., a manufacturer of medical devices, today announced that it is conducting a voluntary recall of certain units of the single-patient use Manual Pulmonary Resuscitator (MPR). The recall only impacts MPRs manufactured from July 2002 – March 2008 and matching the lot numbers listed on the following Unomedical web page: Unomedical MPR Recall. This [...]]]></description>
		<link>http://www.drug-attorneys.com/medical-devices/unomedical-recalls-manual-pulmonary-resuscitators-mprs-10062009</link>
			</item>
	<item>
		<title>New USP Standards for Heparin Products</title>
		<description><![CDATA[New USP Standards for Heparin Products Will Result in Decreased Potency
Adjustments may be Needed to Achieve Desired Anticoagulant Effect in Some Patients
New Heparin to Ship Starting October 8
The U.S. Food and Drug Administration today alerted health care professionals to a change in heparin manufacturing that is expected to decrease the potency of the common anti-clotting [...]]]></description>
		<link>http://www.drug-attorneys.com/fda-reports/fda-alerts/new-usp-standards-for-heparin-products-10012009</link>
			</item>
	<item>
		<title>Philips Recalls Heartstart Fr2+ External Defibrillators</title>
		<description><![CDATA[Philips announced today that it is voluntarily recalling approximately 5,400 HeartStart FR2+ automated external defibrillators (AEDs). This recall is being conducted due to the possibility of a memory chip failure that may render the device inoperable. Only certain HeartStart FR2+ AEDs (models M3860A and M3861A, distributed by Philips; and models M3840A and M3841A, distributed by [...]]]></description>
		<link>http://www.drug-attorneys.com/medical-devices/philips-recalls-heartstart-fr2-external-defibrillators-09282009</link>
			</item>
</channel>
</rss>
